Source: http://www.readbag.com/accessdata-fda-cdrh-docs-pdf5-k052335
Timestamp: 2019-05-21 09:46:38
Document Index: 456611493

Matched Legal Cases: ['§807', '§868', 'art 1', 'art 1', 'arts 800', 'art 807', 'art 801', 'art 820', 'art 801', 'art 807']

Read K052335.pdf
Read K052335.pdf text version
NOV23 2005 510(k) Number: 44flLi45
Accutron, Inc. Date:
Digital Ultra Analgesia Gas Machine
This summary is intended to comply with requirements of the SMDA and 2ICFR§807.92. FDA may make this summary available to the public within 30 days following a finding of substantial equivalence.
510O(k) Applicant
Accutron, Inc. 1733 West Parkside Lane Phoenix, AZ, 85027 USA
510(k) Correspondent
Robert N. Clark, President and Senior Consultant Medical Device Regulatory Advisors 13 605 West 7 1' Ave., Golden, CO 80401 USA
Accutron Digital Ultra Analgesia Gas Machine
21CFR§868.5160 Product Code: BSZ
The Accutron Digital Ultra Analgesia Gas Machine precisely meters oxygen and nitrous oxide medical gases for conscious sedation of patients in dental offices and hospitals. With the device, the attending physician or dentist is able to set both the percentage of nitrous oxide and the total flow to a desired level of sedation and flow. The Digital Ultra Analgesia Gas Machine has been designed with built in safety features that prevent the level of oxygen gas from falling below 30% of total flow, mechanical features that prevent the mix-up of gases, and fail-safe features to prevent the flow of nitrous oxide in the absence of oxygen gas.
Accutron, Inc. Digital Ultra Analgesia Gas Machine
510(k) Number: Date: Page 2 of 2
The Digital Ultra Analgesia Gas Machine is intended for use in nitrous oxide-oxygen sedation systems for delivering to a patient a mixture of nitrous oxide and oxygen gases with a maximum nitrous oxide concentration of 70%.
K970163 Technical Medical Products Model 20 Alpha MX / Model 30 Ultra PC manufactured by Accutron Inc., Phoenix AZ. K945722 Matrx MDM, RA manufactured by Matrx Medical, Inc., Orchard Park, New York.
EN 6060 1-1 / IEC 60601-1, &quot;Medical Electrical Equipment - Part 1: General Requirements for Safety&quot; EN 60601-1-2 / IEC 60601-1-2, &quot;Medical electrical equipment - Part 1-2: General requirements for safety - Collateral standard: Electromagnetic compatibility - Requirements and tests&quot; ISO 5356-1, &quot;Anesthetic and respiratory equipment - conical connectors&quot; ASTM F1054-01, &quot;Standard specification for conical fittings&quot; CGA C-9:1988, &quot;Standard color marking of compressed gas containers for medical use&quot; CGA V-5:2000, &quot;Diameter-Index Safety System (non-interchangeable low pressure connections for medical gas applications)&quot;
The Accutron Digital Ultra Analgesia Gas Machine has been designed to meet the recommendations of the American Dental Association.
This device has been designed to either completely eliminate or mitigate known health hazards associated with the use of the device. Health hazard risk reduction has been accomplished by rigorous application of a risk management program. The user must be qualified in conscious sedation procedures, and must be familiar with all labeling and instructions for use associated with the device. Accutron Inc. believes that the Digital Ultra Analgesia Gas Machine is safe and effective when used as instructed by knowledgeable and trained personnel, and is substantially equivalent to the legally marketed predicate devices.
Accutron, Incorporated C/O Mr. Robert N. Clark President &amp; Senior Consultant Medical Device Regulatory Advisors 13605 West 7 th Avenue Golden, Colorado 80401-4604
Re: K052335 Trade/Device Name: Accutron Digital Ultra Analgesia Gas Machine Regulation Number: 868.5160 Regulation Name: Gas Machine for Anesthesia or Analgesia Regulatory Class: II Product Code: BSZ Dated: November 14, 2005 Received: November 15, 2005
Dear Mr. Clark: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Page 2 - Mr. Clark Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, &quot;Misbranding by reference to premarket notification&quot; (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industrv/support/index.html. Sincerely yours,
2in,tj.~D~ Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
510(k) Number (if known): Device Name: Indications For Use:
K052335
To be used in nitrous oxide-oxygen sedation systems for delivering to a patient a mixture of nitrous oxide and oxygen gases with a maximum nitrous oxide concentration of 70%.
of Anest!iesiology, General Hospi'al _,ton Control, Dental Devices ,.&lt;i ,,tumber. I~ O41 ~'~Page 1 of 1
K052335/S1 Page 5 of 205